Effex is an analytics startup based in Belgium, founded in 2023. The company offers an end-to-end platform for Statistical Design of Experiments. With the slogan "Your end-to-end platform for Statistical Design of Experiments," Effex aims to revolutionize experimental planning and analysis. The platform is designed to save time, resources, and manpower by making physical testing more efficient and sustainable. Effex encourages users to abandon trial & error and one-factor-at-a-time experimentation, offering a novel approach to Design of Experiments. The company's unique methodology, developed under the guidance of Prof. Peter Goos at KU Leuven’s Biostatistics group, sets it apart from existing software. Effex is focused on addressing today's requirements for users who demand the most efficient experimental plans. Notably, the company is developing a future-proof, web-based platform based on customer feedback. As of now, there is no public information available about the last investment and the investors involved in Effex. Effex's innovative approach to experimental design and its commitment to efficiency position it as a promising player in the analytics industry. As the company continues to develop its platform and gain traction in the market, it may attract interest from venture capital firms looking to invest in cutting-edge solutions for experimental planning and analysis.
There is no investment information
No recent news or press coverage available for Effex.